Amid a multi-year surge in vaccine misinformation sparked by the Covid-19 pandemic, social media posts claimed that the ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

Shares in South Africa's Aspen Pharmacare dropped more than 30% on Wednesday, a day after the company issued a profit warning ...

BioNTech to present clinical & pre-clinical data from mRNA and next-generation immuno-oncology priority programmes at AACR 2025: Mainz, Germany Saturday, April 26, 2025, 14:00 Hrs ...

The Senate has unanimously passed a measure that would implement labeling requirements for specific foods containing vaccines ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

Highlights of BioNTech’s oncology programs to be presented at AACR 2025: ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

as it witnessed R22 billion being wiped off its JSE market capitalisation following a fallout related to a contractual dispute with an unnamed client linked to the manufacture of mRNA products.

These risks include a material contractual dispute related to a manufacturing and technology agreement with a contract manufacturing customer for mRNA products. It could not provide further ...